Exit Ranbaxy at around Rs 360-375: Vishal Malkan

Vishal Malkan of malkansview.com told CNBC-TV18, "Ranbaxy Laboratories is the most underperformer in the pharmaceutical space. Though today it is up because of the results, I would suggest the to exit at around Rs 360-375 levels and get into something better like Dr Reddys Laboratories or Divis Laboratories.”

“I would suggest go into Divis Labs because it is a fresh breakout over all time highs and have good potential to go around 15-20 percent in the next one-two quarters,” he added.